chief scientific officer

Tim Mayleben Named President And CEO Of Esperion TherapeuticsEsperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.
HR Notices From October 17The latest staffing and boardroom news from Michigan's technology-focused companies and institutions
HR Notices From September 22